Functional exhaustion of antiviral lymphocytes in COVID-19 patients

Cited by (1,000)

Items 501–600 of 1,000

1. Proteomic investigation reveals dominant alterations of neutrophil degranulation and mRNA translation pathways in patients with COVID-19
   Renuka Bankar, Kruthi Suvarna, Saicharan Ghantasala, Arghya Banerjee, Deeptarup Biswas, Manisha Choudhury, Viswanthram Palanivel, Akanksha Salkar, Ayushi Verma, Avinash Kumar Singh et al. · 2021 · iScience
2. High levels of soluble CD25 in COVID‐19 severity suggest a divergence between anti‐viral and pro‐inflammatory T‐cell responses
   Min Xie, Joseph Yunis, Yin Yao, Jing Cheng Shi, Yang Yang, Pengcheng Zhou, Kaili Liang, Yanmin Wan, Ahmed Murtaza Mehdi, Zhian Chen et al. · 2021 · Clinical & Translational Immunology
3. COVID-IRS: A novel predictive score for risk of invasive mechanical ventilation in patients with COVID-19
   José Antonio García-Gordillo, Antonio Camiro-Zúñiga, Mercedes Aguilar-Soto, Dalia Cuenca, Arturo Cadena‐Fernández, Latife Salame Khouri, Jesica Naanous Rayek, Moisés Mercado, The ARMII Study Group · 2021 · PLoS ONE
4. Herpes Simplex Keratitis in Patients with SARS-CoV-2 Infection: A Series of Five Cases
   Nora Majtánová, Petra Krišková, Petra Kéri, Zlatica Fellner, Juraj Majtán, Petr Kolář · 2021 · Medicina
5. Mild and Asymptomatic COVID-19 Convalescents Present Long-Term Endotype of Immunosuppression Associated With Neutrophil Subsets Possessing Regulatory Functions
   Izabela Siemińska, Kazimierz Węglarczyk, Marcin Surmiak, Dorota Kurowska-Baran, Marek Sanak, Maciej Siedlar, Jarek Baran · 2021 · Frontiers in Immunology
6. SARS-CoV-2 induces mitochondrial dysfunction and cell death by oxidative stress/inflammation in leukocytes of COVID-19 patients
   Joel De la Cruz Enriquez, Emmanuel Rojas-Morales, María Gema Ruíz-García, Julio C. Tobón-Velasco, Jose Carlos Jimenez-Ortega · 2021 · Free Radical Research
7. Tracking the clonal dynamics of SARS-CoV-2-specific T cells in children and adults with mild/asymptomatic COVID-19
   Weng Hua Khoo, Katherine Jackson, Chansavath Phetsouphanh, John Zaunders, José Alquicira-Hernández, Seyhan Yazar, Stephanie Ruiz‐Diaz, Mandeep Singh, Rama Dhenni, Wunna Kyaw et al. · 2022 · Clinical Immunology
8. Systematic review with meta-analysis of active herpesvirus infections in patients with COVID-19: Old players on the new field
   Ana V. Banko, Danijela Miljanovic, Andja M. Cirkovic · 2023 · International Journal of Infectious Diseases
9. International Journal of Current Science Research and Review
   Fredrick Juma Syanya, Wilson Munala Mathia · 2020 · International Journal of Current Science Research and Review
10. Accelerated immune ageing is associated with COVID-19 disease severity
    Janet M. Lord, Tonny Veenith, Jack Sullivan, Archana Sharma‐Oates, Alex G Richter, Neil J. Greening, Hamish J. C. McAuley, Rachael A Evans, Paul A. H. Moss, Shona C. Moore et al. · 2024 · Immunity & Ageing
11. Coronavirus infection and immune system: An insight of COVID-19 in cancer patients
    Alice Indini, Erika Rijavec, Michele Ghidini, Claudia Bareggi, Monica Cattaneo, Barbara Galassi, Donatella Gambini, Francesco Grossi · 2020 · Critical Reviews in Oncology/Hematology
12. Title: Cytokine release syndrome is not usually caused by secondary hemophagocytic lymphohistiocytosis in a cohort of 19 critically ill COVID-19 patients
    Georg Lorenz, Philipp Moog, Quirin Bachmann, Paul Graf La Rosée, Heike Schneider, Michaela Schlegl, Christoph D. Spinner, Uwe W. Heemann, Roland Michael Schmid, Hana Algül et al. · 2020 · Scientific Reports
13. Mechanisms of Dysregulated Humoral and Cellular Immunity by SARS-CoV-2
    N. Taefehshokr, Sina Taefehshokr, B. Heit · 2020 · Pathogens
14. A Comprehensive Summary of the Knowledge on COVID-19 Treatment
    Yu Peng, Hongxun Tao, Senthil Kumaran Satyanarayanan, Kunlin Jin, Huanxing Su · 2021 · Aging and Disease
15. Repurposing of Anticancer Drugs Expands Possibilities for Antiviral and Anti-Inflammatory Discovery in COVID-19
    Mihaela D. Aldea, Jean‐Marie Michot, François‐Xavier Danlos, Antoni Ribas, Jean‐Charles Soria · 2021 · Cancer Discovery
16. Endothelial Senescence and Chronic Fatigue Syndrome, a COVID-19 Based Hypothesis
    Adonis Sfera, C. Osorio, Carlos M. Zapata Martín del Campo, Shaniah Pereida, S. Maurer, J. C. Maldonado, Z. Kozlakidis · 2021 · Frontiers in Cellular Neuroscience
17. Generation of Glucocorticoid Resistant SARS-CoV-2 T-Cells for Adoptive Cell Therapy
    Rafet Başar, Nadima Uprety, Emily L. Ensley, May Daher, Kimberly L. Klein, Fernando D. Martínez, Fleur M. Aung, Mayra Shanley, Bingqian Hu, Elif Gokdemir et al. · 2020 · Cell Reports
18. Adipose-Tissue-Derived Mesenchymal Stem Cells Mediate PD-L1 Overexpression in the White Adipose Tissue of Obese Individuals, Resulting in T Cell Dysfunction
    Assia Eljaafari, Julien Pestel, Brigitte Le Magueresse‐Battistoni, Stéphanie Chanon, Julia Watson, Maud Robert, Emmanuel Disse, Hubert Vidal · 2021 · Cells
19. Binding of phosphatidylserine‐positive microparticles by PBMCs classifies disease severity in COVID‐19 patients
    Lisa Rausch, Konstantin Lutz, Martina Schifferer, Elena Winheim, Rudi Gruber, Elina F. Oesterhaus, Linus Rinke, Johannes C. Hellmuth, Clemens Scherer, Maximilian Muenchhoff et al. · 2021 · Journal of Extracellular Vesicles
20. Innate Immune Response in SARS-CoV-2 Infection
    Giovanna Schiuma, Silvia Beltrami, Daria Bortolotti, Sabrina Rizzo, Roberta Rizzo · 2022 · Microorganisms
21. COVID-19: imbalanced cell-mediated immune response drives to immunopathology
    Jun Wang, Qian Li, Yuanwang Qiu, Hongzhou Lu · 2022 · Emerging Microbes & Infections
22. SARS-CoV-2 modulates inflammatory responses of alveolar epithelial type II cells via PI3K/AKT pathway
    Ahmed Ali Al-Qahtani, Ioanna Pantazi, Fatimah S. Alhamlan, Hani Alothaid, Sabine Matou‐Nasri, George Sourvinos, Eleni Vergadi, Christos Tsatsanis · 2022 · Frontiers in Immunology
23. BTK/ITK dual inhibitors: Modulating immunopathology and lymphopenia for COVID-19 therapy
    Michael C. McGee, Avery August, Weishan Huang · 2020 · Journal of Leukocyte Biology
24. The critical impacts of cytokine storms in respiratory disorders
    Shahana Riyaz Tramboo, Ahmed M. E. Elkhalifa, Syed Quibtiya Khursheed, Sofi Imtiyaz Ali, Naveed Nazir Shah, Syed Taifa, Rabia Rakhshan, Iqra Hussain Shah, Muzafar Ahmad Mir, Masood Malik et al. · 2024 · Heliyon
25. Lung Pathology of COVID-19 in Moscow
    Maria V. Samsonova, L.M. Mikhalyova, O. V. Zairatyants, V.V. Varyasin, A. V. Bykanova, Mishnev Od, Yu.S. Berezovsky, O.A. Tishkevitch, E.A. Gomzikova, A. L. Chernyayev et al. · 2020 · Russian Journal of Archive of Pathology
26. Mitochondrial-targeted ubiquinone: A potential treatment for COVID-19
    Lichen Ouyang, Jie Gong · 2020 · Medical Hypotheses
27. Systemic innate and adaptive immune responses to SARS-CoV-2 as it relates to other coronaviruses
    Patrick O’Connell, Yasser Ali Aldhamen · 2020 · Human Vaccines & Immunotherapeutics
28. Clinical characteristics and survival analysis in critical and non-critical patients with COVID-19 in Wuhan, China: a single-center retrospective case control study
    Ran Tian, Wei Wu, Chunyao Wang, Haiyu Pang, Zhiyu Zhang, Haopeng Xu, Qingfeng Luo, Peng Gao, Jihua Shi, Wenbin Li et al. · 2020 · Scientific Reports
29. Immunomodulation for Severe COVID-19 Pneumonia: The State of the Art
    Yinhua Zhang, Yuanyuan Chen, Zhongji Meng · 2020 · Frontiers in Immunology
30. Cytomegalovirus haemorrhagic enterocolitis associated with severe infection with COVID-19
    Warren C Carll, Mohamed Y. Rady, Marcela A. Salomao, B. M. Patel, Vijay P. Singh, Ayan Sen · 2021 · BMJ Open Gastroenterology
31. SARS-CoV-2 infection and adverse events in patients with cancer receiving immune checkpoint inhibitors: an observational prospective study
    Mario Mandalà, Paul C. Lorigan, Matilde De Luca, Andrea Bianchetti, Barbara Merelli, Anna Bettini, Lucia Bonomi, Sharon H. Nahm, Maria Grazia Vitale, Giorgia Negrini et al. · 2021 · Journal for ImmunoTherapy of Cancer
32. Impact of SARS-CoV-2 on the clinical outcomes and placental pathology of pregnant women and their infants: A systematic review
    Irina I. Oltean, Jason Tran, Sarah Linda Lawrence, Brittany Ann Ruschkowski, Na Zeng, Cameron Bardwell, Youssef Nasr, Joseph de Nanassy, Dina El Demellawy · 2021 · Heliyon
33. A review on the immune responses against novel emerging coronavirus (SARS-CoV-2)
    Ramin Lotfi, Rasoul Nasiri Kalmarzi, Seyed Askar Roghani · 2021 · Immunologic Research
34. SARS-CoV-2-Induced Gut Microbiome Dysbiosis: Implications for Colorectal Cancer
    Mark Howell, Ryan J. Green, Andrew R. McGill, Rinku Dutta, Subhra Mohapatra, Shyam S. Mohapatra · 2021 · Cancers
35. A role for T‐cell exhaustion in Long COVID‐19 and severe outcomes for several categories of COVID‐19 patients
    Kevin Roe · 2021 · Journal of Neuroscience Research
36. Neutrophil Maturation, Reactivity and Granularity Research Parameters to Characterize and Differentiate Convalescent Patients from Active SARS-CoV-2 Infection
    Iwona Kwiecień, Elżbieta Rutkowska, Katarzyna Kulik, Krzysztof Kłos, Katarzyna Plewka, Agata Raniszewska, Piotr Rzepecki, Andrzej Chciałowski · 2021 · Cells
37. Perspective of HLA-G Induced Immunosuppression in SARS-CoV-2 Infection
    Aifen Lin, Wei‐Hua Yan · 2021 · Frontiers in Immunology
38. Inhibitory Immune Checkpoint Receptors and Ligands as Prognostic Biomarkers in COVID-19 Patients
    Mohammad A. Al-Mterin, Alhasan Alsalman, Eyad Elkord · 2022 · Frontiers in Immunology
39. SARS-CoV-2-specific CD4+ T cells are associated with long-term persistence of neutralizing antibodies
    Zhongfang Wang, Xiaoyun Yang, Xinyue Mei, Yumin Zhou, Zhiqiang Tang, Guichang Li, Jiaying Zhong, Mengqiu Yu, Mingzhu Huang, Xiaoling Su et al. · 2022 · Signal Transduction and Targeted Therapy
40. Role of interferons in the antiviral battle: from virus-host crosstalk to prophylactic and therapeutic potential in SARS-CoV-2 infection
    Grigore Mihăescu, Mariana Carmen Chifiriuc, Roxana Filip, Coralia Bleoţu, Lia-Mara Diţu, Marian Constantin, Roxana-Elena Cristian, Raluca Grigore, Serban Vifor Bertesteanu, Gloria Simona Berteșteanu et al. · 2024 · Frontiers in Immunology
41. SARS-CoV-2 infection and stem cells: Interaction and intervention
    Fenggang Yu, Rufu Jia, Yongyong Tang, Jin Liu, Benjie Wei · 2020 · Stem Cell Research
42. Secondary hemophagocytic lymphohistiocytosis versus cytokine release syndrome in severe COVID-19 patients
    Nausheen Hakim, Jeffrey Chi, Coral Olazagasti, Johnson M Liu · 2020 · Experimental Biology and Medicine
43. A Rare Case of Varicella-Zoster Virus Reactivation Following Recovery From COVID-19
    Hardik Dineshbhai Desai, Kamal H. Sharma, Jaimini Patoliya, Elton Ahadov, Neel N Patel · 2021 · Cureus
44. Peripheral Blood Immune Profiling of Convalescent Plasma Donors Reveals Alterations in Specific Immune Subpopulations Even at 2 Months Post SARS-CoV-2 Infection
    Nikolaos Orologas‐Stavrou, Marianna Politou, Pantelis Rousakis, Ioannis V. Kostopoulos, Ioannis Ntanasis‐Stathopoulos, Edison Jahaj, Eleni Tsiligkeridou, Maria Gavriatopoulou, Efstathios Kastritis, Αnastasia Kotanidou et al. · 2020 · Viruses
45. A useful and sensitive marker in the prediction of COVID-19 and disease severity: Thiol
    Ayşe Kaya Kalem, Bircan Kayaaslan, Salim Neşeli̇oğlu, Fatma Eser, İmran Hasanoğlu, Adalet Aypak, Esragül Akıncı, Halise Akça, Özcan Erel, Rahmet Güner · 2021 · Free Radical Biology and Medicine
46. COVID-19 illness and autoimmune diseases: recent insights
    Juan Li, Honghui Liu, Xiao‐Dong Yin, Chengcheng Li, Jing Wang · 2021 · Inflammation Research
47. Natural Polyphenols as Immunomodulators to Rescue Immune Response Homeostasis: Quercetin as a Research Model against Severe COVID-19
    Roberta Bernini, Francesca Velotti · 2021 · Molecules
48. TP53 Gene Therapy as a Potential Treatment for Patients with COVID-19
    Joe B. Harford, Sang Soo Kim, Kathleen F. Pirollo, Esther H. Chang · 2022 · Viruses
49. Pattern-recognition receptors (PRRs) in SARS-CoV-2
    Alireza Isazadeh, Javad Ahmadian Heris, Parviz Shahabi, Reza Mohammadinasab, Navid Shomali, Hadi Nasiri, Zahra Valedkarimi, Ahmad Jamei Khosroshahi, Saba Hajazimian, Morteza Akbari et al. · 2023 · Life Sciences
50. Recruited and Tissue-Resident Natural Killer Cells in the Lung During Infection and Cancer
    Miriam Franklin, Emma Connolly, Tracy Hussell · 2022 · Frontiers in Immunology
51. Cell‐mediated immunity to SARS‐CoV‐2
    Xiaolin Wang, Jingang Gui · 2020 · Pediatric Investigation
52. Association of Metformin with Susceptibility to COVID-19 in People with Type 2 Diabetes
    Jingya Wang, Jennifer M. Cooper, Krishna Margadhamane Gokhale, Dionisio Acosta, Samir Dhalla, Nathan Byne, Joht Singh Chandan, Astha Anand, Kelvin Okoth, Anuradhaa Subramanian et al. · 2021 · The Journal of Clinical Endocrinology & Metabolism
53. Platelet parameters and leukocyte morphology is altered in COVID-19 patients compared to non-COVID-19 patients with similar symptomatology
    Anne Bryde Alnor, Maria Boysen Sandberg, Barbara Ella Toftanes, Pernille Just Vinholt · 2021 · Scandinavian Journal of Clinical and Laboratory Investigation
54. Broad phenotypic alterations and potential dysfunction of lymphocytes in individuals clinically recovered from COVID-19
    Jingyi Yang, Maohua Zhong, Ejuan Zhang, Ke Hong, Qingyu Yang, Dihan Zhou, Jianbo Xia, Yao-Qing Chen, Mingbo Sun, Bali Zhao et al. · 2021 · Journal of Molecular Cell Biology
55. Host factors facilitating SARS‐CoV‐2 virus infection and replication in the lungs
    Sébastien Boutin, Dagmar Hildebrand, Steeve Boulant, Michael Kreuter, Jule Rüter, Srinivas Reddy Pallerla, Thirumalaisamy Palanichamy Velavan, Dennis Nurjadi · 2021 · Cellular and Molecular Life Sciences
56. Inhibitory Immune Checkpoint Molecules and Exhaustion of T cells in COVID-19
    Martina Barnova, Anna Bobčáková, Veronika Urdova, Radovan Kosturiak, Lenka Kapustova, Dušan Dobrota, Miloš Jeseňák · 2021 · Physiological Research
57. The function of specialized pro-resolving endogenous lipid mediators, vitamins, and other micronutrients in the control of the inflammatory processes: Possible role in patients with SARS-CoV-2 related infection
    Claudio Giuseppe Gallo, Sirio Fiorino, Giovanni Posabella, Donato Antonacci, Antonio Tropeano, Emanuele Pausini, Carlotta Pausini, Tommaso Guarniero, Wandong Hong, Enrico Giampieri et al. · 2022 · Prostaglandins & Other Lipid Mediators
58. CD8+ T Cells in SARS-CoV-2 Induced Disease and Cancer—Clinical Perspectives
    Keywan Mortezaee, Jamal Majidpoor · 2022 · Frontiers in Immunology
59. Epidemiological and clinical characteristics of patients hospitalised with COVID-19 in Kenya: a multicentre cohort study
    Loice Achieng Ombajo, Nyamai Mutono, Paul Sudi, Patrick M. Mutua, Mohammed Sood, Alliyy Loo, Phoebe Juma, Jackline A. Odhiambo, Reena Shah, Frederick K. Wangai et al. · 2022 · BMJ Open
60. Rural-urban outcome differences associated with COVID-19 hospitalizations in North Carolina
    Sheri A. Denslow, Jason R. Wingert, Amresh D Hanchate, Aubri Rote, Daniel J. Westreich, Laura Sexton, Kedai Cheng, Janis Curtis, W. Schuyler Jones, Amy Joy Lanou et al. · 2022 · PLoS ONE
61. The derived neutrophil to lymphocyte ratio can be the predictor of prognosis for COVID-19 Omicron BA.2 infected patients
    Weiji Qiu, Qiqing Shi, Fang Chen, Qian Wu, Xiya Yu, Lize Xiong · 2022 · Frontiers in Immunology
62. Coronavirus Disease 2019 (COVID-19): A Haematologist’s Perspective
    Carmen Ka Man Cheung, Man Fai Law, Grace Chung-Yan Lui, Sunny Hei Wong, Raymond S. M. Wong · 2020 · Acta Haematologica
63. Biological characteristics and biomarkers of novel SARS-CoV-2 facilitated rapid development and implementation of diagnostic tools and surveillance measures
    Gajanan Sampatrao Ghodake, Surendra Krushna Shinde, Avinash Ashok Kadam, Rijuta Ganesh Saratale, Ganesh Dattatraya Saratale, Asad Syed, Abdallah Mohamed Elgorban, Najat Marraiki, Dae-Young Kim · 2021 · Biosensors and Bioelectronics
64. The effect of age on the clinical and immune characteristics of critically ill patients with COVID-19: A preliminary report
    Chunling Hu, Junlu Li, Xia Xing, Jing Gao, Shilong Zhao, Lihua Xing · 2021 · PLoS ONE
65. COVID-19 and Pregnancy: Vertical Transmission and Inflammation Impact on Newborns
    M. Joma, Claire-Maelle Fovet, N. Seddiki, P. Gressens, M. Laforge · 2021 · Vaccines
66. Obesity and severe coronavirus disease 2019: molecular mechanisms, paths forward, and therapeutic opportunities
    Tiantian Yan, Rong Xiao, Nannan Wang, Ruoyu Shang, Guoan Lin · 2021 · Theranostics
67. Impaired Antibody-Dependent Cellular Cytotoxicity in a Spanish Cohort of Patients With COVID-19 Admitted to the ICU
    Lorena Vigón, Javier García‐Pérez, Sara Rodríguez-Mora, Montserrat Torres, Elena Mateos, María Castillo de la Osa, Miguel Cervero, Rosa Malo de Molina, Cristina Navarro, María Aránzazu Murciano-Antón et al. · 2021 · Frontiers in Immunology
68. Individualized Constellation of Killer Cell Immunoglobulin-Like Receptors and Cognate HLA Class I Ligands that Controls Natural Killer Cell Antiviral Immunity Predisposes COVID-19
    Stalinraja Maruthamuthu, Karan Rajalingam, Navchetan Kaur, Maelig G. Morvan, Jair Soto, Nancy Lee, Denice Kong, Zicheng Hu, Kevin R. Reyes, Dianna Ng et al. · 2022 · Frontiers in Genetics
69. Clinical progress in MSC-based therapies for the management of severe COVID-19
    Maria Rossello-Gelabert, Ainhoa Gonzalez‐Pujana, Manoli Igartúa, Edorta Santos‐Vizcaíno, Rosa Marı́a Hernández · 2022 · Cytokine & Growth Factor Reviews
70. Herpes Simplex Virus 1 (HSV-1) Reactivation in Critically Ill COVID-19 Patients: A Brief Narrative Review
    Daniele Roberto Giacobbe, Stefano Di Bella, Antonio Lovecchio, Lorenzo Ball, Andrea De Maria, Antonio Vena, Bianca Marisa Bruzzone, Giancarlo Icardi, Paolo P. Pelosi, Roberto Luzzati et al. · 2022 · Infectious Diseases and Therapy
71. COVID‐19: A trigger of autoimmune diseases
    Arghavan Zebardast, Ali Hasanzadeh, Arefeh Ebrahimian, Mehdi Tourani, Yousef Yahyapour · 2023 · Cell Biology International
72. NK cell subsets and dysfunction during viral infection: a new avenue for therapeutics?
    Jacob C. Bjorgen, Jenna K. Dick, Ross T. Cromarty, Geoffrey T. Hart, Joshua Rhein · 2023 · Frontiers in Immunology
73. Mitigating Coronavirus Induced Dysfunctional Immunity for At-Risk Populations in COVID-19: Trained Immunity, BCG and “New Old Friends”
    Thomas O. Kleen, Alicia A. Galdon, Andrew S. MacDonald, Angus George Dalgleish · 2020 · Frontiers in Immunology
74. Potential Therapeutic Benefits of Dipyridamole in COVID-19 Patients
    Kholoud F. Aliter, Rami A. Al‐Horani · 2020 · Current Pharmaceutical Design
75. T cell phenotypes in COVID-19 - a living review
    Stephanie Jean Hanna, Amy Susan Codd, Ester Gea‐Mallorquí, David Oliver Scourfield, Felix Clemens Richter, Kristin Ladell, Mariana Borsa, Ewoud Bernardus Compeer, Owen R. Moon, Sarah A. E. Galloway et al. · 2020 · Oxford Open Immunology
76. Characterizing the immune responses of those who survived or succumbed to COVID-19: Can immunological signatures predict outcome?
    Ramin Sami, Farshid Fathi, Nahid Eskandari, Meysam Ahmadi, Reza Arefnezhad, Hossein Motedayyen · 2021 · Cytokine
77. T cell counts and IL-6 concentration in blood of North African COVID-19 patients are two independent prognostic factors for severe disease and death
    Brahim Belaid, Lydia Lamara Mahammed, Belgacem Mihi, Sarah Yasmine Rahali, Asma Djidjeli, Zineb Larab, Lilya Berkani, Ismahane Berkane, Wafa Sayah, Fatma Merah et al. · 2021 · Journal of Leukocyte Biology
78. Mesenchymal stem cell alongside exosomes as a novel cell-based therapy for COVID-19: A review study
    Meruyert Dauletova, Hafsan Hafsan, Negah Mahhengam, Angelina Olegovna Zekiy, Majid Ahmadi, Homayoon Siahmansouri · 2021 · Clinical Immunology
79. Immunological perspectives on the pathogenesis, diagnosis, prevention and treatment of COVID-19
    Yanghong Ni, Aqu Alu, Lei Hong, Yang Wang, Min Wu, Xiawei Wei · 2021 · Molecular Biomedicine
80. Vitamin D and Exercise Are Major Determinants of Natural Killer Cell Activity, Which Is Age- and Gender-Specific
    Sooyeon Oh, Sukyung Chun, Sena Hwang, Jong-Seok Kim, Yuri Cho, Jooho Lee, KyuBum Kwack, Sang‐Woon Choi · 2021 · Frontiers in Immunology
81. Intravenous immunoglobulin as an important adjunct in the prevention and therapy of coronavirus 2019 disease
    Maria Giovanna Danieli, Mario Andrea Piga, Alberto Paladini, Eleonora Longhi, Cristina Mezzanotte, Gianluca Moroncini, Yehuda Shoenfeld · 2021 · Scandinavian Journal of Immunology
82. ALVR109, an off-the-shelf partially HLA matched SARS-CoV-2–specific T cell therapy, to treat refractory severe COVID-19 pneumonia in a heart transplant patient: Case report
    Katalin Martits‐Chalangari, Cedric W. Spak, Medhat Z. Askar, Aaron D. Killian, Tammy L. Fisher, Ercem S. Atillasoy, William L. Marshall, David McNeel, Michael D. Miller, Susan K. Mathai et al. · 2021 · American Journal of Transplantation
83. COVID‐19 immunopathology with emphasis on Th17 response and cell‐based immunomodulation therapy: Potential targets and challenges
    Arash Pourgholaminejad, Saghar Pahlavanneshan, Mohsen Basiri · 2021 · Scandinavian Journal of Immunology
84. CD8+ T-cell immune escape by SARS-CoV-2 variants of concern
    Arnaud John Kombe Kombe, Fleury Augustin Nsole Biteghe, Zélia Nelly Ndoutoume, Tengchuan Jin · 2022 · Frontiers in Immunology
85. Innate and adaptive immune response in SARS-CoV-2 infection-Current perspectives
    Qiugang Zhu, Yan Xu, Ting Wang, Feiting Xie · 2022 · Frontiers in Immunology
86. Two distinct immunopathological profiles in autopsy lungs of COVID-19
    Ronny Nienhold, Yari Ciani, Viktor Hendrik Koelzer, Alexandar Tzankov, Jasmin D. Haslbauer, Thomas Menter, Nathalie Schwab, Maurice Johannes Henkel, Angela Frank, Veronika Zsikla et al. · 2020 · medRxiv
87. Long-Term Existence of SARS-CoV-2 in COVID-19 Patients: Host Immunity, Viral Virulence, and Transmissibility
    Xingyu Wang, Kun Lun Huang, Haini Jiang, Lijuan Hua, Weiwei Yu, Dan Ding, Ke Wang, Xiaopan Li, Zhong Zou, Meilin Jin et al. · 2020 · Virologica Sinica
88. The Virological, Immunological, and Imaging Approaches for COVID-19 Diagnosis and Research
    An S. Tan, Sanjna Nilesh Nerurkar, Wei Chang Colin Tan, Denise L M Goh, Chi Peng Timothy Lai, Joe Poh-Sheng Yeong · 2020 · SLAS TECHNOLOGY
89. Vaccines for COVID-19: perspectives from nucleic acid vaccines to BCG as delivery vector system
    Nina Marí Gual Pimenta de Queiroz, Fabio Vitarelli Marinho, Marcelo Chagas, Luciana C. C. Leite, E. Jane Homan, Mariana T. Q. de Magalhães, Sergio Costa Oliveira · 2020 · Microbes and Infection
90. Sex differences in clinical characteristics and risk factors for mortality among severe patients with COVID-19: a retrospective study
    Wating Su, Zhen Qiu, Lu Zhou, Jiabao Hou, Yafeng Wang, Fengnan Huang, Yi Zhang, Yifan Jia, Jun Zhou, Danyong Liu et al. · 2020 · Aging
91. Recent findings on the Coronavirus disease 2019 (COVID-19); immunopathogenesis and immunotherapeutics
    Negin Ebrahimi, Saeed Aslani, Farhad Babaie, Maryam Hemmatzadeh, Ramin Hosseinzadeh, Zeinab Joneidi, Zahra Mehdizadeh Tourzani, Nafiseh Pakravan, Hamed Mohammadi · 2020 · International Immunopharmacology
92. Predictive monitoring and therapeutic immune biomarkers in the management of clinical complications of COVID-19
    Hamed Fouladseresht, Mehrnoosh Doroudchi, Najmeh Rokhtabnak, Hossein Abdolrahimzadehfard, Amir Roudgari, Golnar Sabetian, Shahram Paydar · 2020 · Cytokine & Growth Factor Reviews
93. COVID-19: The Emerging Immunopathological Determinants for Recovery or Death
    Tanveer Ahmad, Rituparna Chaudhuri, Mohan Chandra Joshi, Ahmad Almatroudi, Arshad Husain Rahmani, Syed Mansoor Ali · 2020 · Frontiers in Microbiology
94. Pronounce expression of Tim-3 and CD39 but not PD1 defines CD8 T cells in critical Covid-19 patients
    Mehdi Shahbazi, Zahra Moulana, Mahdi Sepidarkish, Mojgan Bagherzadeh, Maryam Rezanejad, Mohammad Mirzakhani, Mohammad Jafari, Mousa Mohammadnia‐Afrouzi · 2021 · Microbial Pathogenesis
95. COVID-19 infection and nanomedicine applications for development of vaccines and therapeutics: An overview and future perspectives based on polymersomes
    Mohammad A. I. Al-Hatamleh, Ma’mon M. Hatmal, Walhan Alshaer, Engku Nur Syafirah Engku Abd Rahman, Manali Haniti Mohd-Zahid, Dina M. Alhaj-Qasem, Chan Yean Yean, Iskandar Zulkarnain Alias, Juhana Jaafar, Khalid Ferji et al. · 2021 · European Journal of Pharmacology
96. Heparin binding protein in severe COVID-19—A prospective observational cohort study
    Lisa Mellhammar, Louise Thelaus, Sixten Elén, Jane Fisher, Adam Linder · 2021 · PLoS ONE
97. Immunological and inflammatory profiles during acute and convalescent phases of severe/ critically ill COVID-19 patients
    Qigao Chen, Baodan Yu, Yihao Yang, Jiewen Huang, Ying Liang, Jing Zhou, Lianzhong Li, Xuechun Peng, Bolin Cheng, Yongping Lin · 2021 · International Immunopharmacology
98. Immunological Biomarkers of Fatal COVID-19: A Study of 868 Patients
    Esperanza Martín‐Sánchez, Juan‐José Garcés, Catarina Maia, Susana Inogés, Ascensión López-Dı́az de Cerio, Francisco Carmona-Torre, Marta Marín‐Oto, Félix Alegre, Elvira Molano, Mirian Fernández-Alonso et al. · 2021 · Frontiers in Immunology
99. COVID-19 pandemic as a risk factor for the reactivation of herpes viruses
    María Dolores Maldonado y Aibar, María Dolores Maldonado y Aibar, María Ángeles Pérez-San-Gregorio · 2021 · Epidemiology and Infection
100. Immunological Profiling of COVID-19 Patients with Pulmonary Sequelae
     Jianghua Wu, Lu Tang, Yanling Ma, Yu Li, Dongmei Zhang, Qian Li, Heng Mei, Yu Hu · 2021 · mBio